Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces
about
Surface modification of biomaterials: a quest for blood compatibilityImproved Hemocompatibility of Multilumen Catheters via Nitric Oxide (NO) Release from S-Nitroso-N-acetylpenicillamine (SNAP) Composite Filled Lumen.The artificial endotheliumReduction in Thrombosis and Bacterial Adhesion with 7 Day Implantation of S-Nitroso-N-acetylpenicillamine (SNAP)-Doped Elast-eon E2As Catheters in SheepBergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.BF3·Et2O Catalysed 4-Aryl-3-phenyl-benzopyrones, Pro-SERMs, and Their Characterization.Layer-by-layer heparinization of decellularized liver matrices to reduce thrombogenicity of tissue engineered grafts.Bioactive technologies for hemocompatibility.Hemocompatibility of styrenic block copolymers for use in prosthetic heart valves.Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?Development of cardiovascular bypass grafts: endothelialization and applications of nanotechnology.Chemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: A review.In situ endothelialization of intravascular stents from progenitor stem cells coated with nanocomposite and functionalized biomolecules.Surface chemistry to minimize fouling from blood-based fluids.Arterial tissue regeneration for pediatric applications: inspiration from up-to-date tissue-engineered vascular bypass grafts.Alternative conduits for microvascular anastomoses.Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).Surface-modified polymers for cardiac tissue engineering.UV surface modification of a new nanocomposite polymer to improve cytocompatibility.Biomechanics and biocompatibility of the perfect conduit-can we build one?Assessment of the potential of progenitor stem cells extracted from human peripheral blood for seeding a novel vascular graft material.Current Strategies in Cardiovascular Biomaterial Functionalization.ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.A silver nanocomposite biomaterial for blood-contacting implants.Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2.Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells LinesZwitterionic poly(2-oxazoline)s as promising candidates for blood contacting applicationsNanocapsules for 5-fluorouracil delivery decorated with a poly(2-ethylhexyl methacrylate-co-7-(4-trifluoromethyl)coumarin acrylamide) cross-linked wallThrombocompatibility of sol-gel titanium dioxide coatings deposited on stainless steel substrate
P2860
Q28728811-2CAFA8A2-A655-438F-82C3-360E7FBB046AQ33647184-7B676FCB-6F44-43A5-8FC4-96538DA73741Q34852479-D56E4BBB-FBD2-44E8-A525-9C8FB3F3E427Q35077593-F79C9A05-ABAE-4B4D-8026-54EC790DFD49Q35786199-69DE3E7D-D6C0-4A40-B546-5554F014EC84Q36059489-3C3A4039-3957-42DA-BE07-2CC87042CBB6Q36165449-0F24CFDF-0AE1-42C6-8771-B64417C6B25DQ36315142-26EF602C-716E-45B2-8AC7-E8C95DB3C468Q36403365-6F57A8E6-E650-4E03-819C-9F0B52BE88A1Q36412659-030ADC52-5A67-4BCD-B1C0-D271C28B371CQ37304690-2B6F0EBC-E314-4CBB-A8B3-7A24C389B762Q37431543-EFC55B6B-2711-4A1B-9FA3-34D14AE8F60DQ37859059-7470A645-E579-4F34-9888-AE4AA4EAA696Q38024635-EA7ACE84-2159-4020-A48C-456A98D397BFQ38095588-1AD45FC8-F88D-4144-9D6F-474D0BDE74E3Q38130596-6A702DC4-3FA3-43CA-9C0F-5A61FF5B1F38Q38844542-37DE95CC-2F1D-4758-980C-E95B86050332Q40083319-4ED373EA-BA99-4534-B7FD-79785114E9A1Q40125843-BE90ED31-11E8-4763-85F0-3923566696F7Q42552216-BC207393-8BCA-43F1-8D06-4F32621D9D95Q46705818-3A00D132-2DD8-4577-9EE7-93F95B117BD2Q47162762-003BC859-46DB-4A00-A3FF-E1093B64B929Q47232377-3CB3A26E-1A37-4A95-822E-BB014746AF1BQ50248233-8B9ACD60-FF26-4FB6-8831-98270372AE18Q51499309-35074DF0-2C1C-4DB6-8AFD-B25FA63F4134Q57166828-D7BDE575-798C-4186-9778-5328A6D285B5Q57368130-94AD60E0-0945-4D7F-8BF6-65F8AE866CB8Q57376793-4D50F2D9-2C5B-478E-8F23-F8ACB94143C5Q58148533-AC59BD68-8EEE-4C81-B0CE-DFDFE8CE8A5D
P2860
Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@ast
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@en
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@nl
type
label
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@ast
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@en
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@nl
prefLabel
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@ast
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@en
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@nl
P2093
P356
P1433
P1476
Anticoagulant and antiplatelet ...... th usages to engineer surfaces
@en
P2093
Alexander M Seifalian
Alok Tiwari
Asmeret G Kidane
Henryk Salacinski
K Richard Bruckdorfer
P304
P356
10.1021/BM0344553
P407
P577
2004-01-01T00:00:00Z